SCHEMBL19082411

SCHEMBL19082411

c1ccc2c(c1)ccc1c2sc2ccc3c4cc(-c5c6ccccc6c(-c6ccc7c(c6)oc6ccccc67)c6ccccc56)ccc4sc3c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A1 P04798 5/20 0.34
CYP1B1 Q16678 5/20 0.34
CYP1A2 P05177 3/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
HCRTR1 O43613 1/20 0.33
PRKDC P78527 1/20 0.33
DUSP3 P51452 1/20 0.33
ESR2 Q92731 2/20 0.32
MMP12 P39900 1/20 0.31
MMP13 P45452 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
ESR1 P03372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944473 0.96 AHR (0.37) AHRTDP1L3MBTL1CYP1A1CYP1B1
SCHEMBL17247148 0.92 KDM4E (0.37) AHRTDP1L3MBTL1CYP1A1CYP1B1
SCHEMBL19082403 0.91 TDP1 (0.37) AHRTDP1L3MBTL1CYP1A1CYP1A2
SCHEMBL19110310 0.89 PRKDC (0.37) AHRTDP1L3MBTL1MEN1MAPT
SCHEMBL17944925 0.89 CYP1A1 (0.40) AHRCYP1A1CYP1B1CYP1A2MAPT
SCHEMBL17944250 0.89 AHR (0.37) AHRTDP1L3MBTL1MEN1MAPT
SCHEMBL19082417 0.88 AHR (0.35) AHRTDP1L3MBTL1CYP1A1CYP1B1
SCHEMBL19082407 0.88 KDM4E (0.35) AHRTDP1L3MBTL1CYP1A1CYP1B1
SCHEMBL19082406 0.87 KDM4E (0.34) AHRTDP1L3MBTL1CYP1A1CYP1B1
SCHEMBL19110314 0.87 AHR (0.35) AHRTDP1L3MBTL1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 AHR 2453/4885TDP1 2322/4885L3MBTL1 1245/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 AHR 2453/4885TDP1 2322/4885L3MBTL1 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.